Zhende Medical Ownership

603301 Stock   22.66  0.02  0.09%   
Zhende Medical Co retains a total of 266.45 Million outstanding shares. Zhende Medical maintains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 60.35 (%) of Zhende Medical outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Zhende Medical in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Zhende Medical, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
The current year's Dividends Paid is expected to grow to about (402.5 M). As of December 23, 2024, Common Stock Shares Outstanding is expected to decline to about 239.8 M. In addition to that, Net Income Applicable To Common Shares is expected to decline to about 584 M.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Zhende Medical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Zhende Stock Ownership Analysis

About 60.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.08. In the past many companies with similar price-to-book ratios have beat the market. Zhende Medical last dividend was issued on the 3rd of July 2024. The entity had 1.4:1 split on the 8th of June 2020. For more info on Zhende Medical Co please contact the company at 86 575 8875 1963 or go to https://www.zhende.com.

Zhende Medical Outstanding Bonds

Zhende Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Zhende Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Zhende bonds can be classified according to their maturity, which is the date when Zhende Medical Co has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Currently Active Assets on Macroaxis

Other Information on Investing in Zhende Stock

Zhende Medical financial ratios help investors to determine whether Zhende Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zhende with respect to the benefits of owning Zhende Medical security.